Using these anti-NMT1 and anti-NMT2 mAb preparations, we initiated an immunohistochemical tissue survey of NMT1 and NMT2 protein levels in a large cohort of normal and breast cancer tissue samples and sought relationships among NMT protein levels, clinical outcomes, and pathologic features of the breast tumors. This evidence concerns the gene NMT2 and breast cancer.